Short Interest in electroCore, Inc. (NASDAQ:ECOR) Decreases By 22.8%

electroCore, Inc. (NASDAQ:ECOR) saw a large drop in short interest during the month of January. As of January 15th, there was short interest totalling 89,500 shares, a drop of 22.8% from the December 31st total of 115,900 shares. Currently, 1.7% of the company’s shares are short sold. Based on an average daily volume of 124,900 shares, the short-interest ratio is presently 0.7 days.

Analyst Ratings Changes

Separately, HC Wainwright lifted their target price on shares of electroCore from $22.00 to $25.00 and gave the stock a “buy” rating in a research report on Wednesday, December 18th.

Institutional Trading of electroCore

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. International Assets Investment Management LLC grew its holdings in shares of electroCore by 689.1% in the third quarter. International Assets Investment Management LLC now owns 535,146 shares of the company’s stock worth $3,864,000 after purchasing an additional 467,326 shares during the last quarter. Renaissance Technologies LLC boosted its position in electroCore by 3.4% during the 2nd quarter. Renaissance Technologies LLC now owns 68,786 shares of the company’s stock valued at $442,000 after buying an additional 2,270 shares during the period. Geode Capital Management LLC grew its holdings in electroCore by 10.3% in the 3rd quarter. Geode Capital Management LLC now owns 63,485 shares of the company’s stock worth $458,000 after acquiring an additional 5,951 shares during the last quarter. Finally, HighTower Advisors LLC purchased a new position in shares of electroCore in the third quarter valued at about $255,000. Institutional investors own 26.74% of the company’s stock.

electroCore Trading Down 3.6 %

NASDAQ ECOR opened at $15.58 on Thursday. The firm has a market cap of $103.70 million, a PE ratio of -8.51 and a beta of 0.50. electroCore has a 1-year low of $5.32 and a 1-year high of $18.67. The stock has a 50-day moving average of $14.77 and a 200-day moving average of $10.17.

About electroCore

electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.